Loading...

Verano Holdings Corp.

VRNOFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.59
$-0.13(-7.56%)

Verano Holdings Corp. (VRNOF) Stock Overview

Explore Verano Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap582.5M
P/E Ratio-1.70
EPS (TTM)$-0.99
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Week$0.55
1 Month$0.65
3 Months$0.38
1 Year Target$2.28

VRNOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Verano Holdings Corp. (VRNOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.27, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.70 and a market capitalization of 582.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;